To Top

Doctors in Gangnam


Ophthalmology

Dr. Sung Yong Kang

2017-12-20 11:54
Director kys

Sung Yong Kang, MD

BIOGRAPHY

Former Representative Doctor/CEO at Eyereum Ophthalmic Clinic

Degree and Career
  • Graduated from Yonsei University College of Medicine
  • Ophthalmologist at Yonsei University Severance Hospital
  • Out-patient Clinical Associate Professor at ophthalmology class of Ulsan University Asan Hospital
  • Out-patient Assistant Clinical Associate Professor at ophthalmology class of Yonsei University College of Medicine
  • Clinic-Lecturer at ophthalmology department of Yonsei University Severance Hospital
  • Researcher at Yonsei University Severance Hospital Clinical Trial Center
  • Listed in Marquis Whos Who in 2013
  • Author of 34 SCI(E) graded papers (by 21/03/2017)
  • Has rights to 6 patents in Implantable Contact Lens/Small Incision Lenticule
  • Extraction/LASEK/Cataract Surgery related techniques/tools
  • Listed in the Power List 50 in European Ophthalmology Journal ‘The Ophthalmologist’ in 2017

Academic Background&Award
  • Full member at The Korean Glaucoma Society
  • Full member at The Korean Ophthalmological Society
  • Full member at ASCRS (American Society of Cataract and Refractive Surgery)
  • Full member at KSCRS (Korean Society of Cataract and Refractive Surgery)
  • Full member at KCLS (The Korean Contact Lens Study Society)
  • Full member at AOGS (Asia-Oceania Glaucoma Interest Group)
  • Full member at SEAGIG (South East Asia Glaucoma Interest Group)
  • Full member at WGC (World Glaucoma Congress)
  • Full member at ARVO (Association for Research in Vision Science and Ophthalmology)
  • Full member at AAO (American Academy of Ophthalmology)
  • Appointed doctor by Asia-Pacific Schwind Amaris Training Center
  • Best Skilled User in Altiflex nominated by OPHTEC of Netherlands
  • World Best Doctor nominated by OPHTEC of Netherlands in 2015
  • MARIS750s LASER ASIA-PACIFIC PRINICIPAL INVESTIGATOR nominated by SCHWIND of Germany
  • ICL/TICL Global Expert Surgeon nominated by STAAR of USA
  • World Class Pioneer, Global Expert in Altiflex/Beriplex
  • Asia-Pacific Advisory Board of OPHTEC of Netherlands
  • Reference Doctor of AMARIS RED 1050RS of SCHWIND of Germany
  • The one and only entrusted Principal Investigator of SPT
  • Awarded 'BEST PAPER' at Asia-Pacific ICL Symposium
  • Reference Doctor of Aqua Toric ICL
  • Entrusted International Speaker of SMILE/LASIK of ZEISS of Germany
  • Official Medical Advisory Board of Avedro of USA
  • Appointed as AVEDRO AMBASSADOR of Avedro of USA
  • Awarded 'Study in clinical, electron microscopic, atomic microscopic of low energy SMILE surgery'
  • at the 117th Korean Ophthalmological Society Academic Award

Interview

[Medical News] Sung Yong Kang, MD of Eyereum Ophthalmic Clinic, nominated as the 50 world’s most influential ophthalmologist of 2017

Sung Yong Kang, MD of Eyereum Ophthalmic Clinic has been honored to be nominated in The Power List 50 by the European Ophthalmology Journal ‘The Ophthalmologist’ this year. The Power List 50 includes Pears Keane and the 6 medical team members of Moorfields Eye Hospital of U.K., Doctor Alex Huang from Doheny Eye Institute of UCLA, and the world’s most authoritative ophthalmologists with Sung Yong Kang, MD being the only Korean doctor.

‘The Power list’ of the Ophthalmologist has been nominating the 50 world’s most influential ophthalmologists annually and this year, with their new theme ‘Rising Star’, they proceeded an early vote on the subject of the world’s note-worthy medical teams, with the participants of the ophthalmology field. According to the European local presses, Sung Yong Kang, MD is a doctor to represent the Asian region and his active academic activities and papers have been recognized to be nominated in the Power List 50. Sung Yong Kang, MD of the great medical cases in the adverse reaction field and the SCI papers has been lecturing in the world’s academic society, on the subjects of laser vision correction, light sensitivity issues after LASIK/LASEK, regression in vision, and keratoconus(Keratectasia). His paper from last year about COWAVE to prevent and cure optical side effects has been officially selected in the SCI graded academic journal, JCRS(Journal of Cataract & Refractive Surgery) and with the world’s great scholars, he investigated and established the normal range and the general index for safety in cornea durability(rigidity) to prevent keratoconus, and as a result, he succeeded to transfer the normal value of cornea durability of Asians’ eyes to the general index for safety statistically.

Sung Yong Kang, MD with his continuous researches covering all fields in ophthalmology and international academic activities, he has accomplished a research achievement worthy of close attention in ReLEX SMILE field. Moreover, he has suggested the low energy SMILE LASIK to prevent the optical side effects and to improve the quality in vision, based on the references such as the differences in bubble production, the restoration speed of visual acuity, and effects in correction of higher order aberration, over the laser energy strength at the cornea lenticule separation stage in SMILE surgery. In other words, the low energy SMILE LASIK means to low the laser equipment’s energy intensity to the critical point where the cornea desquamation is possible, in the operation and minimize the occurrence of gas-bubbles in the cornea so after the operation, the blue symptoms are improved and the cornea is left smooth. As a result, the night vision and light sensitivity issues caused by the higher order aberration are reduced and the clearer visions are achieved.

The outstanding result in the operation of low energy SMILE LASIK has drawn attentions internationally and Dan Z. Reinstein of U.K., an authority in ReLEX SMILE, has participated in the joint research. The research led the Korean doctor to an academic award from the Korean Ophthalmological Society.

In this May, the effect of improvement in vision from the low energy SMILE LASIK was officially selected by AJO (American Journal of Ophthalmology), the highly cited researcher with the paper citation index of 4.021 and the SCI graded academic journal. The participant of the Ophthalmic Clinic has said stated that it is beyond just the international activities or a individual honor of a Korean doctor but, it is rather more meaningful since this results in reporting Korea’s medical improvements and the take-off as a powerful medical nation.

more

Consultation Reservation